Navigation Links
ASCRS Releases Position Statement on Two Established Ophthalmic Practices
Date:8/19/2015

The American Society of Cataract and Refractive Surgery (ASCRS) has released an official position statement opposing directives that restrict two well-established pre-surgical ophthalmic practices: the use of diluted povidone-iodine solution for topical infection prophylaxis and the use of multidose topical eye drops on multiple patients. The position statement, developed by the ASCRS Cataract Clinical Committee, comes in the wake of some surgery centers being compelled to cease certain long accepted topical treatments for preoperative patients.

“Some members reported that surveyors have arbitrarily proscribed these well established and common practices, without any evidence that they pose greater risk,” said ASCRS Past President and Cataract Clinical Committee member David F. Chang, MD.

ASCRS POSITION STATEMENT:

Current literature strongly supports the use of preoperative povidone-iodine solution for cataract (ophthalmic) surgery antisepsis and endophthalmitis prevention. Specifically, instillation of five percent povidone-iodine solution in the conjunctival sac has been shown to be effective for endophthalmitis prophylaxis. This practice has been used almost universally in ophthalmic surgery for decades.

One common method of preparing the five percent solution is by diluting commercially available ten percent povidone iodine (Betadine) with a saline solution. A recent ASCRS survey revealed that one in three ASCs (ambulatory surgery centers) prepare their surgical prep in this way. This practice has been shown to be safe and effective despite the labeling “Do not use in the eye,” present on the 10 percent Betadine solution. More recently, individually packaged five percent povidone-iodine preps have become commercially available, but at a significant cost premium.

Another well-established practice is the use of multidose eye drops on multiple patients as part of the preoperative surgical protocol (i.e. dilating drops, NSAID etc.). The safety and cost effectiveness of multidose bottles are well recognized in the clinic and in the surgery setting. Safety guidelines have been established for the safe use of these products including: expiration 28 days after initial use, proper dispensing technique, and discarding of any bottle with suspected tip contamination.

The ASCRS Cataract Clinical Committee strongly supports the current established practice of utilizing multidose eye drops on multiple patients, when proper protocols are followed. Furthermore, diluting 10 percent povidone iodine for surgical prophylaxis remains a common and appropriate option in preparing the surgical prophylaxis.

This position statement is provided for information and educational use only. It is not intended to establish a standard of care or dictate a particular course of treatment. ASCRS members and other physicians must exercise their independent medical judgment in making treatment decisions for their patients.

“The Cataract Clinical Committee is not recommending or suggesting that there is only one best practice,” said Dr. Chang. “Rather, we want to defend those facilities that choose to use multi-use bottles or dilute 10 percent Betadine, based on the best medical judgment of their clinical staff.”

Read the full story at http://www.prweb.com/releases/2015/08/prweb12907908.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. ASCRS Foundation and Sen. Rand Paul Support Mission to Perform 200 Cataract Surgeries in Guatemala: A Nine-Day Mission Will Launch a Major Five-Year Commitment in the Reg
2. Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego
3. Khanna Vision Institute anounced Dr. Khanna attended ASCRS meeting in San Diego focused on cataracts and refractive surgery.
4. Fenway Health Releases Transgender Awareness Week 2013 Infographic
5. Pixel Film Studios Releases PRO16mm Vintage Film Effects for Final Cut Pro X
6. Forget Computers Releases Device Scout 3.0 for Robot Cloud — Manage All Apple Devices Smarter, Faster
7. Viewpoints Industry TV Releases November Air Dates for Champaign, Illinois and Surrounding Area
8. Searchen Releases Statement on Celebrity and Athletic Endorsement Study
9. Spiritual River Releases Restyled Ebook on Creative Recovery
10. National Patient Safety Foundation Releases Educational Module on Health IT
11. 1-800-MEDIGAP Releases New Information Source and Television Ad About Medicare Supplement Plans to Help Educate and Support Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... ... adolescents and adults, today announced the restructuring of the Strategic Advisory Board (SAB) ... to meet the demand for behavioral health care. , We are ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... IT services, announced that Angel Rosa has been appointed as Senior Vice President ... developing and implementing new services, growing and nurturing high performing teams, and driving ...
(Date:6/20/2019)... ... , ... The 2019 Colorado Classic® presented by VF Corporation will showcase its ... elite teams, organizers announced today. The top-four domestic teams in USA Cycling’s Pro ... , The standalone pro women’s road race has received commitments from 16 teams, ...
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor ... , one of the world’s largest job and recruiting sites, released its annual report ... throughout North America and parts of Europe. , Smile Brands, a leading dental support ...
(Date:6/19/2019)... ... June 19, 2019 , ... The FSH Society announced ... in Marseille, France. The conference is widely seen as the premier global platform ... Nearly 200 researchers, clinicians, industry representatives and patient advocates are attending. , Researchers ...
Breaking Medicine News(10 mins):
(Date:6/20/2019)... NEW YORK (PRWEB) , ... June 20, 2019 ... ... showed signs that exposure to dust from the World Trade Center site had ... according to a study by Mount Sinai researchers in Molecular Cancer Research in ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... clinical trials, today announced its scientific and technological experts will present a series ... Information Association (DIA) Annual Meeting in San Diego, June 23-27. , ERT’s ...
(Date:6/20/2019)... N.C. (PRWEB) , ... June 20, 2019 , ... ... (SCTM) demonstrates how preconditioning mesenchymal stem cells (MSCs) enhances their ability to treat ... to developing more effective MSC treatments for clinical application, according to Ben Antebi, ...
Breaking Medicine Technology: